,iter,drug,tissue,model,feature,BIC,acc,tp,tn,fp,fn,roc_auc,brier,log_loss
0,0,crizotinib,BRCA,LR,TARGET,5.475733734920662,0.625,0,5,1,2,0.3333333333333333,0.23599296177810414,0.6650483837126215
1,1,crizotinib,BRCA,LR,TARGET,5.373183276498131,0.375,1,2,4,1,0.5,0.25029204305706376,0.6937293491493297
2,2,crizotinib,BRCA,LR,TARGET,5.354080930281342,0.875,1,6,0,1,0.75,0.2397082934830111,0.6724697887942888
3,0,crizotinib,BRCA,KNN,TARGET,NA,0.75,0,6,0,2,0.4166666666666667,0.28125,9.097556744849282
4,1,crizotinib,BRCA,KNN,TARGET,NA,0.75,0,6,0,2,0.16666666666666669,0.28125,9.154754383505178
5,2,crizotinib,BRCA,KNN,TARGET,NA,0.625,0,5,1,2,0.45833333333333337,0.34375,9.270843539989269
